
Flexible organic electrodes convert infrared light into nerve signals in damaged retinas
In an important step toward visual prostheses, biocompatible electrodes can convert infrared light into nerve impulses, as demonstrated by a team at TU Wien

In an important step toward visual prostheses, biocompatible electrodes can convert infrared light into nerve impulses, as demonstrated by a team at TU Wien

Not long ago, the idea of diagnosing a disease with a droplet of blood was considered a pipe dream. Today, this technology could soon become a reality.

3D printed blood vessels on glass that mimic blood vessel anatomy and the fluid dynamics of blood flow could be an invaluable tool in studying the causes of stroke, new research from a University of Sydney team has found and it has already led to important insights.

Complex digital images of tissue samples that can take an experienced pathologist up to 20 minutes to annotate could be analyzed in just one minute using a new AI tool developed by researchers at the University of Cambridge.

Colonoscopies may one day have some competition—researchers report in ACS Sensors that they’ve developed a sensor made of tiny microspheres packed with blood-sensing bacteria that detect markers of gastrointestinal disease. Taken orally, the miniature “pills” also contain magnetic particles that make them easy to collect from stool.

Columbia University researchers are the first to show that focused ultrasound—a noninvasive technique that uses sound waves to enhance the delivery of drugs into the brain—can be safely used in children being treated for brain cancer.

Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic eye, new research shows.

Levita Magnetics has received FDA 510(k) clearance for its Magnetic Surgical System (MSS) to be used in certain pediatric surgeries, with the first U.S. surgery performed at Cleveland Clinic Children’s earlier this month.

Having been commercially available for less than 12 months, the system is now offered in over 60 US clinics.

PLANO, Texas, Nov. 18, 2025 /PRNewswire/ — Vesalio, a leader in innovative thrombectomy solutions, today announced two new FDA 510(k) clearances for its aspiration devices, designed for peripheral and neurovascular applications. These clearances mark a key milestone in Vesalio’s evolution toward providing a complete suite of thrombectomy products across multiple vascular territories.